Delivery Order SPE2DB20D2002-SPE2DB23FL36W

Award Date 5/3/23
Potential Completion Date 5/4/23
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,363.27, is for the delivery of Telmisartan 80 mg tablets to support military healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of January 9, 2024. This order is part of a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,759,756 units of the medication Telmisartan 80 mg tablets. The contract has a ceiling value of $43,130.77 and runs through December 19, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,984.66, is for the delivery of Telmisartan 80 mg tablets. This order was placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued up to $999,999,999.00, serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.28 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of September 26, 2023 and was awarded on September 25, 2023. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,345.76, is for the delivery of Telmisartan 80 mg tablets to support U.S. government healthcare programs. The contract has a performance period ending on September 28, 2023 and is a firm fixed-price delivery order. This award is not associated with a set-aside program, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,598.33, is for the delivery of Telmisartan 80 mg Tablets in 30 count packages. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,594.40, is for the delivery of Telmisartan 80 mg tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of December 13, 2021. This award is associated with a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as...
This federal contract award is a delivery order with a firm fixed price of $1,140.03 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is to provide 4,561,706,864 Telmisartan 80 mg tablets in 30-count packages, with a completion date of August 7, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which covers...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,237.60 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. The award has an ultimate completion date of January 31, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 80 mg tablets. The $2,698.54 firm fixed-price contract has an ultimate completion date of April 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB23FL36W
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is valued at $2,017.78 and covers the delivery of Telmisartan 80 mg tablets to support military and federal healthcare programs.

The contract is a firm fixed price Indefinite Delivery Contract (IDC) that serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA, Department of Justice Federal Bureau of Investigation, and other federal agencies. The IDC with the DLA Troop Support Medical is valued at up to $999,999,999.00 and runs through November 2026, enabling efficient procurement of essential medications and medical commodities for military treatment facilities, veterans' healthcare programs, and other federal beneficiaries. This contract award was made through full and open competition without any set-aside designation.

Generated 5/9/25, 9:58 AM